Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin for Renal Hemodynamics in Type 1 Diabetes
NCT00297401Phase 3Completed
- Sponsor
- Chromaderm
- Start
- Mar 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ruboxistaurin in diabetic nephropathy (DN), sponsored by Chromaderm. Started Mar 2006; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00297401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297401.